Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Italy
Clinical trial register · Italy

Clinical Trials in Italy

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6788 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:19 UTC
6788
Studies in scope
all four open statuses
4077
Recruiting now
open to new participants
1016
Lead sponsors
across recruiting studies
Top sites
Milan 9 Cremona 5 Candiolo 4 Meldola 4 Roma 2

Trials in this register

11 of 6788 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Astellas Pharma Global Development, Inc.
Phase 2
240
Bari, Foggia, Meldola, Milan, Naples, Rome
2026-03-12
Recruiting
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
NCT07005154Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer
Astellas Pharma Global Development, Inc.
Phase 2
218
Milan, Roma, Trento
2025-08-19
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
NCT06901531Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
Astellas Pharma Global Development, Inc.
Phase 3
500
Ancona, Bergamo, Bologna, Brescia, Candiolo, Cremona, Florence, Meldola
2025-05-22
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
982
Bologna, Genova, Milan, Mirano, Pavia, Reggio Emilia, Terni
2024-07-31
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
98
Milan, Padova, Torino
2024-01-16
Recruiting
Astellas Pharma Global Development, Inc.
Phase 1
398
Milan, Rozzano, Verona
2022-06-07
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
886
Areezo, Candiolo, Cremona, Genova, Meldola, Milan, Pisa, Terni
2020-03-30
Active, closed
A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer
NCT03816163Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc.
Phase 2
393
Rozzano, Candiolo, Cremona, Lombardia, Milan, Toscana, Veneto
2019-03-15
Active, closed
A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer
NCT03505320Pharmacokinetics of Zolbetuximab, Gastric Cancer, Gastro-esophageal Junction (GEJ) Cancer, Pharmacokinetics of Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 2
143
Milan, Naples, Padova, Pisa
2018-06-29
Active, closed
A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.
NCT03504397Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
Astellas Pharma Global Development, Inc.
Phase 3
565
Meldola, Monza, Vicenza, Ancona, Bergamo, Cremona, Milan, Modena
2018-06-21
Active, closed
Astellas Pharma Global Development, Inc.
Phase 2
900
Faenza (RA), Arezzo, Candiolo, Cremona, Forlì, Roma, Toscana, Trento
2016-12-22
Rows per page Showing 1–11 of 11
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 16 November 2026. https://priyalifescience.com/clinical-trials-italy

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,788 studies in total at the last sync on 13 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 11 of those studies that match the filters currently applied.

How many clinical trials are recruiting in Italy?

4 of the 11 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 7 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase, 11 studies
PhaseStudiesRecruitingShare
Phase 25245.5%
Phase 35145.5%
Phase 1119.1%

Most active sponsors

Lead sponsors with the most studies
Lead sponsorStudiesRecruiting
Astellas Pharma Global Development, Inc.114

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Prostate Cancer (2) Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer (2) Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer (2) Metastatic Gastric Adenocarcinoma or Cancer (2) Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma (2) Pancreatic Cancer (1) Metastatic Pancreatic Cancer (1) Metastatic Pancreatic Adenocarcinoma (1) Gastric Adenocarcinoma (1) Gastroesophageal Junction (GEJ) Adenocarcinoma (1) Pancreatic Adenocarcinoma (1) Chronic Kidney Disease (1) Renal Anemia (1) Hot Flashes (1) Urothelial Cancer (1)
→

Browse trials by site location

Milan (9) Cremona (5) Candiolo (4) Meldola (4) Roma (2) Trento (2) Rozzano (2) Ancona (2) Bergamo (2) Padova (2) Bologna (2) Genova (2) Terni (2) Pisa (2)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.